Zonisamid EQL Pharma now approved in Denmark
The medical product Zonisamid EQL Pharma has now been approved for sale by the Danish Medicines Agency. Zonisamid EQL Pharma is an anticonvulsant being used in the treatment of epilepsy. The name of the original product is Zonegran (Eisai Limited). The total turnover of the original product in Denmark is approximately SEK 12 million annually. Currently there are two generic competitors on the market in addition to the original. EQL Pharma aims to start selling Zonisamid EQL Pharma in Q1 2017 at the latest. "We are pleased that Zonisamid EQL Pharma has now been approved in Denmark